IWMPD
CLDX icon

Integrated Wealth Management (Palm Desert)’s Celldex Therapeutics CLDX Stock Holding History

Integrated Wealth Management (Palm Desert)’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-13
Closed -$5K – 1312
2015
Q2 		$5K Hold
13
– – ﹤0.01% 953
2015
Q1 		$5K Buy
+13
New +$4.65K ﹤0.01% 920

Other funds holding CLDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Integrated Wealth Management (Palm Desert)'s CLDX Position: Q3 2015 in Review

Integrated Wealth Management (Palm Desert) sold out of Celldex Therapeutics (CLDX) in Q3 2015, closing a stake of 13 shares — an estimated $5K sold.

Integrated Wealth Management (Palm Desert) first reported a position in CLDX in Q1 2015 and held it in 2 quarters. The position peaked at $5K in Q2 2015. 162 funds tracked by Wall St. Rank hold CLDX as of Q3 2015.

  • Integrated Wealth Management (Palm Desert) reported no remaining Celldex Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Integrated Wealth Management (Palm Desert) sold 13 Celldex Therapeutics shares in Q3 2015, an estimated $5K.
  • Integrated Wealth Management (Palm Desert) first reported a position in Celldex Therapeutics in Q1 2015 and held it in 2 quarters.
  • Integrated Wealth Management (Palm Desert)'s Celldex Therapeutics position peaked at $5K in Q2 2015.
  • 162 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2015.

Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q3 2015, filed 13 Oct 2015.